Skip to main content

Table 4 Urinary biomarkers of T2DM and DKD patients with different HbA1c levels

From: Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study

 

T2DM or DKD patients with HbA1c < 7.0% (n = 44)

T2DM or DKD patients with HbA1c ≥ 7.0% (n = 104)

p value

uNGAL (ng/ml)

48.5 (22.5, 91.8)

37.5 (19.3, 89.8)

0.279

uCLU (ng/ml)

434.3 (140.1, 858.5)

358.2 (185.2, 662.3)

0.925

uCysC (ng/ml)

0.37 (0.22, 1.02)

0.35 (0.23, 0.68)

0.528

  1. T2DM type 2 diabetic mellitus, DKD diabetic kidney disease, HbA 1c haemoglobin A1C, uNGAL urinary neutrophil gelatinase-associated lipocalin, uCLU urinary clusterin, uCysC urinary Cystatin C